Oncolytics Biotech OverviewOncolytics Biotech EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ONCY.
Quarterly EBIT
-$9.28M
↓ 32.6% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$31.08M
↑ 6.55% YoY
Trailing 12 months ending Mar 31, 2026
Oncolytics Biotech OverviewEBIT (Earnings Before Interest and Taxes) analysis for ONCY.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026